格列美脲

CAS号
93479-97-1
CCD编号
CCD00178754
分子式
C24 H34 N4 O5 S
分子量
490.622

基本信息

产品名称: 格列美脲
CAS: 93479-97-1
中文同义词: 格列美脲
英文同义词: 3-ETHYL-4-METHYL-N-(4-(N-((1R,4R)-4-METHYLCYCLOHEXYLCARBAMOYL)SULFAMOYL)PHENETHYL)-2-OXO-2,5-DIHYDRO-1H-PYRROLE-1-CARBOXAMIDE ; TRANS-1-(4-(2-(3-ETHYL-4-METHYL-2-OXO-2,5-DIHYDRO-1H-PYRROLE-1-CARBOXAMIDO)ETHYL)PHENYLSULFONYL)-3-(4-METHYLCYCLOHEXYL)UREA ; GLIMEPIRIDE ; GLIMEPIRIDE, USP28 ; 3-ETHYL-2,5-DIHYDRO-4-METHYL-N-[2-[4-[[[(TRANS-4-METHYLCYCLO-HEXYL)AMINO]CARBONYL]AMINO]SULFONYL]PHENYL]ETHYL-2-OXO-1H-PYRROLE-1-CARBOXAMIDE ; 3-ETHYL-4-METHYL-N-[2-(4-[[(TRANS-4-METHYLCYCLOHEXYL)CARBAMOYL]SULFAMOYL]PHENYL)ETHYL]-2-OXO-2,5-DIHYDRO-1H-PYRROLE-1-CARBOXAMIDE ; 1-[[P-[2-(3-ETHYL-4-METHYL-2-OXO-3-PYRROLINE-1-CARBOXAMIDO)ETHYL]PHENYL]SULFONYL]-3-(TRANS-4-METHYLCYCLOHEXYL)UREA ; GLIMPERIDE ; GLIMY ; 3-ETHYL-4-METHYL-N-[2-[4-[(TRANS-4-METHYLCYCLOHEXYL) CARBAMOYLSULFAMOYL]PHENYL]ETHYL]-2-OXO-5H-PYRROL-1-CARBOXAMIDE ; AMARYL ; GLISTA OD
MDL号: MFCD00878417
氢键受体数量: 9
氢键供体数量: 3
Smile: CCC1=C(CN(C1=O)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)N[C@H]3CC[C@@H](CC3)C)C
InChi: InChI=1S/C24H34N4O5S/c1-4-21-17(3)15-28(22(21)29)24(31)25-14-13-18-7-11-20(12-8-18)34(32,33)27-23(30)26-19-9-5-16(2)6-10-19/h7-8,11-12,16,19H,4-6,9-10,13-15H2,1-3H3,(H,25,31)(H2,26,27,30)/t16-,19-
InChiKey: InChIKey=WIGIZIANZCJQQY-RUCARUNLSA-N

性质

注解: APPLICATION: GLIMEPIRIDE IS CURRENTLY USED TO TREAT TYPE 2 DIABETES
BIOCHEM/PHYSIOL ACTIONS: GLIMEPIRIDE IS A POTENT BLOCKER OF CARDIAC KATP CHANNELS ACTIVATED BY PINACIDIL WITH AN IC50 OF 6.8 NM
FOR SYSTEM SUITABILITY
GENERAL DESCRIPTION: THIS PRODUCT IS PROVIDED AS DELIVERED AND SPECIFIED BY THE ISSUING PHARMACOPOEIA. ALL INFORMATION PROVIDED IN SUPPORT OF THIS PRODUCT, INCLUDING MSDS AND ANY PRODUCT INFORMATION LEAFLETS HAVE BEEN DEVELOPED AND ISSUED UNDER THE AUTHORITY OF THE ISSUING PHARMACOPOEIA. FOR FURTHER INFORMATION AND SUPPORT PLEASE GO TO THE WEBSITE OF THE ISSUING PHARMACOPOEIA
OTHER NOTES: SALES RESTRICTIONS MAY APPLY

安全信息

WGK德国: 3

* If the product has intellectual property rights, a license granted is must or contact us.